Alethio Therapeutics
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
About
Alethio Therapeutics develops disease-modifying medicines for myeloproliferative neoplasms, a group of chronic blood cancers. The company combines deep clinical and scientific expertise with its ARTEMIS platform and patient-derived data to discover targeted therapies intended to eliminate cancer-driving cells rather than only manage symptoms. Its pipeline includes ATX-011, a mutation-agnostic antibody being advanced for essential thrombocythemia.
Summary
Alethio Therapeutics is a Biotech company, founded in 2021.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alethio-therapeutics"><img src="https://indexed.vc/api/badge/company/alethio-therapeutics" alt="Alethio Therapeutics on Indexed.vc" width="260" height="76" /></a>